Back
Soleno Therapeutics, Inc. 10K Form
Sell
43
SLNO
Soleno Therapeutics, Inc.
Last Price:
$39.05
Seasonality Move:
17.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SLNO News And Ratings
See the #1 stock for the next 7 days that we like better than SLNO
SLNO Financial Statistics
Sales & Book Value
| Annual Sales: | $190.4M |
|---|---|
| Cash Flow: | $48.6M |
| Price / Cash Flow: | 43.1 |
| Annual Sales: | $8.61 |
| Price / Book: | 4.66 |
Profitability
| EPS (TTM): | 0.22280 |
|---|---|
| Net Income (TTM): | $20.5M |
| Gross Margin: | $187.7M |
| Return on Equity: | 6.16% |
| Return on Assets: | 4.77% |
Soleno Therapeutics, Inc. Earnings Forecast
Key Soleno Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for SLNO is 98.58%.
-
The Selling, General & Administrative Expenses for SLNO have been equal to 69.39% of Gross Profit Margin.
-
The Research & Development expenses have been 21.34% of Revenue.
-
The Interest Expense is 26.74% of Operating Income.
-
The Net Earning history of SLNO is 10.75% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 9 years.
Soleno Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SLNO |
| CUSIP: | 834203 |
| Website: | soleno.life |
Debt
| Debt-to-Equity Ratio: | 0.12 |
|---|---|
| Current Ratio: | 5.8 |
| Quick Ratio: | 5.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 99.95 |
|---|---|
| Forward P/E Ratio: | 18.32 |
SLNO Technical Analysis vs Fundamental Analysis
Sell
43
Soleno Therapeutics, Inc. (SLNO)
is a Sell
Is Soleno Therapeutics, Inc. a Buy or a Sell?
-
Soleno Therapeutics, Inc. stock is rated a SellThe current Soleno Therapeutics, Inc. [SLNO] share price is $39.07. The Score for SLNO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.